BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23719191)

  • 1. Identification of functional nucleotide and haplotype variants in the promoter of the CEBPE gene.
    Ryoo H; Kong M; Kim Y; Lee C
    J Hum Genet; 2013 Sep; 58(9):600-3. PubMed ID: 23719191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEBPE promoter SNPs, caught red handed? A commentary on identification of functional nucleotide and haplotype variants in the promoter of the CEBPE gene.
    Xu H; Yang JJ
    J Hum Genet; 2013 Sep; 58(9):571-2. PubMed ID: 23903072
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of functional haplotypes in the promoter region of the LST1 gene.
    Woo J; Lee C
    Biochem Genet; 2014 Aug; 52(7-8):365-71. PubMed ID: 24803336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls.
    Wang C; Chen J; Sun H; Sun L; Liu Y
    Ann Hematol; 2015 Feb; 94(2):181-5. PubMed ID: 25195121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential promoter activity by nucleotide substitution at a type 2 diabetes genome-wide association study signal upstream of the wolframin gene.
    Ryu J; Lee C
    J Diabetes; 2016 Mar; 8(2):253-9. PubMed ID: 25800097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
    Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
    Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.
    Bhandari P; Ahmad F; Mandava S; Das BR
    Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau haplotypes regulate transcription and are associated with Parkinson's disease.
    Kwok JB; Teber ET; Loy C; Hallupp M; Nicholson G; Mellick GD; Buchanan DD; Silburn PA; Schofield PR
    Ann Neurol; 2004 Mar; 55(3):329-34. PubMed ID: 14991810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
    Wiemels JL; de Smith AJ; Xiao J; Lee ST; Muench MO; Fomin ME; Zhou M; Hansen HM; Termuhlen A; Metayer C; Walsh KM
    Leukemia; 2016 May; 30(5):1194-7. PubMed ID: 26437776
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
    Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
    Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
    Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
    Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
    Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia.
    Al-Shakfa F; Dulucq S; Brukner I; Milacic I; Ansari M; Beaulieu P; Moghrabi A; Laverdière C; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Krajinovic M
    Clin Cancer Res; 2009 Nov; 15(22):6931-8. PubMed ID: 19861437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional analyses of polymorphism haplotypes of protein phosphatase 2A-Aα gene promoter.
    Lin YC; Chen HF; Lin LN; Luo J; Li W; Zhang SJ; Li XJ; Hu YM; Chen YX; Chen W; Lin ZN
    Mutat Res; 2011 Nov; 716(1-2):66-75. PubMed ID: 21889517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CEBPE rs2239633 genetic polymorphism on susceptibility to childhood acute lymphoblastic leukemia: an updated meta-analysis.
    Liu J; Weiling G; Xueqin L; Liang X; Linhong W; Zhongwen C
    Environ Health Prev Med; 2021 Jan; 26(1):2. PubMed ID: 33397280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro functional assay of alleles and haplotypes of two COL1A1-promoter SNPs.
    García-Giralt N; Enjuanes A; Bustamante M; Mellibovsky L; Nogués X; Carreras R; Díez-Pérez A; Grinberg D; Balcells S
    Bone; 2005 May; 36(5):902-8. PubMed ID: 15814304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
    Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
    Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.
    Studd JB; Yang M; Li Z; Vijayakrishnan J; Lu Y; Yeoh AE; Paulsson K; Houlston RS
    Leukemia; 2019 Jan; 33(1):1-14. PubMed ID: 29977016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia.
    Pierini V; Nofrini V; La Starza R; Barba G; Vitale A; Di Raimondo F; Matteucci C; Crescenzi B; Elia L; Gorello P; Storlazzi CT; Mecucci C
    Cancer Genet; 2011 Oct; 204(10):563-8. PubMed ID: 22137487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
    Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
    Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.